These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21976669)
1. Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli. Boncela J; Przygodzka P; Papiewska-Pajak I; Wyroba E; Cierniewski CS J Biol Chem; 2011 Dec; 286(50):43164-71. PubMed ID: 21976669 [TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor type 1 interacts with alpha3 subunit of proteasome and modulates its activity. Boncela J; Przygodzka P; Papiewska-Pajak I; Wyroba E; Osinska M; Cierniewski CS J Biol Chem; 2011 Feb; 286(8):6820-31. PubMed ID: 21135093 [TBL] [Abstract][Full Text] [Related]
3. The role of proteasome beta subunits in gastrin-mediated transcription of plasminogen activator inhibitor-2 and regenerating protein1. O'Hara A; Howarth A; Varro A; Dimaline R PLoS One; 2013; 8(3):e59913. PubMed ID: 23544109 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. Hamaguchi E; Takamura T; Shimizu A; Nagai Y J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369 [TBL] [Abstract][Full Text] [Related]
5. Interaction of plasminogen activator inhibitor-2 and proteasome subunit, beta type 1. Fan J; Zhang YQ; Li P; Hou M; Tan L; Wang X; Zhu YS Acta Biochim Biophys Sin (Shanghai); 2004 Jan; 36(1):42-6. PubMed ID: 14732874 [TBL] [Abstract][Full Text] [Related]
6. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells. Schleef RR; Loskutoff DJ; Podor TJ J Cell Biol; 1991 Jun; 113(6):1413-23. PubMed ID: 2045419 [TBL] [Abstract][Full Text] [Related]
7. Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis. Fish RJ; Kruithof EK Exp Cell Res; 2006 Feb; 312(3):350-61. PubMed ID: 16330024 [TBL] [Abstract][Full Text] [Related]
8. Identification of interaction between PAI-2 and IRF-3. Zhang YQ; Li P; Hou M; Wang X; Fan J; Tan L; Zhu YS Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jul; 35(7):661-5. PubMed ID: 12883638 [TBL] [Abstract][Full Text] [Related]
10. Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes. Liu YX; Hu ZY; Liu K; Byrne S; Zou RJ; Ny T; d'Lacey C; Ockleford CD Placenta; 1998; 19(2-3):171-80. PubMed ID: 9548184 [TBL] [Abstract][Full Text] [Related]
11. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis. Dickinson JL; Norris BJ; Jensen PH; Antalis TM Cell Death Differ; 1998 Feb; 5(2):163-71. PubMed ID: 10200461 [TBL] [Abstract][Full Text] [Related]
12. Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1. Almeida-Vega S; Catlow K; Kenny S; Dimaline R; Varro A Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G414-23. PubMed ID: 19074642 [TBL] [Abstract][Full Text] [Related]
14. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Comparison with plasminogen activator inhibitor-1 synthesis. Zoellner H; Wojta J; Gallicchio M; McGrath K; Hamilton JA Thromb Haemost; 1993 Feb; 69(2):135-40. PubMed ID: 8456426 [TBL] [Abstract][Full Text] [Related]
16. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258 [TBL] [Abstract][Full Text] [Related]
17. Successful silencing of plasminogen activator inhibitor-1 in human vascular endothelial cells using small interfering RNA. Hecke A; Brooks H; Meryet-Figuière M; Minne S; Konstantinides S; Hasenfuss G; Lebleu B; Schäfer K Thromb Haemost; 2006 May; 95(5):857-64. PubMed ID: 16676078 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. van Hinsbergh VW; Kooistra T; van den Berg EA; Princen HM; Fiers W; Emeis JJ Blood; 1988 Nov; 72(5):1467-73. PubMed ID: 3140909 [TBL] [Abstract][Full Text] [Related]
19. Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Zhao R; Ma X; Xie X; Shen GX Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E104-11. PubMed ID: 19401454 [TBL] [Abstract][Full Text] [Related]
20. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. Sawdey M; Podor TJ; Loskutoff DJ J Biol Chem; 1989 Jun; 264(18):10396-401. PubMed ID: 2499579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]